tadalafil has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Numata, K; Shibata, Y; Shimoda, K; Shioya, A; Tokuda, Y | 1 |
| Alonso-Pulpón, L; García Suárez, A; Gómez-Bueno, M; Jaramillo, N; Ortega López, A; Sayago, I; Segovia, J | 1 |
2 other study(ies) available for tadalafil and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
The Development of Cerebral Venous Thrombosis after Tadalafil Ingestion in a Patient with Antiphospholipid Syndrome.
Topics: Antiphospholipid Syndrome; Brain; Humans; Intracranial Thrombosis; Magnetic Resonance Imaging; Male; Middle Aged; Tadalafil | 2017 |
Combined pulmonary vasodilator therapy and endovascular intervention for Hughes-Stovin syndrome.
Topics: Antiphospholipid Syndrome; Carbolines; Combined Modality Therapy; Endovascular Procedures; Humans; Male; Middle Aged; Tadalafil; Vasodilator Agents | 2015 |